Navigation Links
Experts examine causes, treatment and prevention of glaucoma
Date:3/4/2009

Although scientists know progressive degeneration of retinal ganglion cells and their axons is the primary cause of glaucoma, researchers have yet to identify a way to stop or prevent the degeneration.

The challenge to find a solution brought together a panel of 39 scientists to discuss the factors that may contribute to the disease. The report from the Fourth Annual ARVO/Pfizer Ophthalmics Research Institute Conference examined four areas of research into the cause of glaucomatous neurodegeneration and is published in the March 2009 issue of Association for Research in Vision and Ophthalmology's peer-reviewed journal Investigative Ophthalmology & Visual Science (IOVS).

The World Health Organization estimates that 65 million people worldwide have the disease, which is the second-leading cause of blindness. According to the report by Glgn Tezel, MD, "The Role of Glia, Mitochondria, and the Immune System in Glaucoma: Fourth Annual ARVO/Pfizer Ophthalmics Research Institute Conference," recent research indicates that a variety of independent events on the cellular level of the eye can interact to contribute to glaucoma.

One conference session addressed the function of glial cells, which play many roles in support of neurons throughout the body, including those in the visual system. When glaucoma stress conditions appear, glial cells may not be able to adequately support neurons or perform their other functions, especially in older patients.

In another session, researchers discussed problems related to mitochondria, which provide energy to neurons and may prove to be a pathway to prevent neural degeneration in glaucoma patients.

"Targeting mitochondrial events using a specific chemical inhibitor or genetic manipulation appears to be a logical approach for neuroprotection," the report stated.

A discussion on immune response and its effect on glaucoma suggested that the response may initially slow the degeneration of the critical neurons, but the immunity protection itself may lead to problems if not properly controlled. The session called for more study about whether immune activity creates or worsens the neuron degeneration in glaucoma.

The conference concluded with a call for more research on how these factors interact, and asked participants to search for a better understanding of the precise cellular mechanisms related to glaucoma to help find treatments that manipulate the immune system into repairing neural tissue and improving the outlook for those susceptible to glaucoma.


'/>"/>

Contact: Joanne Olson
jolson@arvo.org
240-221-2923
Association for Research in Vision and Ophthalmology
Source:Eurekalert

Related medicine news :

1. SilverCensus.com Names Consumer Affairs Advocate, Healthcare Experts to Provide Free Educational Support for Seniors
2. Policy experts urge scrutiny of senior tax breaks
3. Interview with GI Experts: Discussions in Clostridium difficile
4. Burn rehabilitation experts at UT Southwestern outline best treatments for post-burn itching
5. Rush University Medical Center experts present latest research findings at AAOS meeting
6. Health experts urge supermarket pharmacies to get smart about free antibiotics
7. Experts Call for FDA Regulation of Tobacco Products
8. Experts in Government, Public Health, Public Policy and Science Outline Blueprint for Reducing Death and Disease From Tobacco in the United States
9. Avon Foundation Convened Breast Cancer Experts in Miami to Address Prevention Strategies at Annual Forum
10. International Panel of Experts Gather for Roundtable Consensus Regarding Multiple Myeloma Related Disease
11. BurrellesLuce VP Johna Burke Among Measurement Experts To Speak at Feb. 25 Meeting of PRSA's National Capital Chapter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, ... Elite. The attorneys chosen by their peers for this recognition are considered among the ... Traurig Shareholders received special honors as members of this year’s Legal Elite Hall of ...
(Date:6/24/2016)... ... ... Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair ... hour by 2020 and then adjusting it yearly to increase at the same rate as ... the wage floor does not erode again, and make future increases more predictable. , The ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Living, is proud to recognize Dr. Barry M. Weintraub as a prominent plastic ... most beautiful women in the world, and the most handsome men, look naturally ...
(Date:6/24/2016)... ... , ... National recruitment firm Slone Partners is pleased to announce ... experience, as Vice President of North American Capital Sales at HTG Molecular . ... sales team in the commercialization of the HTG EdgeSeq system and associated reagents in ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016   Bay Area Lyme Foundation , ... Center for Tick Borne Illness , Harvard Medical ... Hacking Medicine, University of California, Berkeley, and the ... five finalists of Lyme Innovation , the ... 100 scientists, clinicians, researchers, entrepreneurs, and investors from ...
(Date:6/24/2016)... , June 24, 2016  American Respiratory Labs (ARL), a ... now able to perform sophisticated lung assessments in patients, homes, thanks ... Inc. Patients are no longer limited to having ... PRO ® , ARL patients like Jeanne R. of ... the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
Breaking Medicine Technology: